Table of contents
Volume 92, Issue 10
Published online 17 May 2005 (1817-1954)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Book Review
Editorial
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas FREE
A Fusco, G Viglietto and M Santoro
Br J Cancer 92: 1817-1818; doi:10.1038/sj.bjc.6602556
Minireviews
Intensity-modulated radiation therapy: emerging cancer treatment technology FREE
T S Hong, M A Ritter, W A Tomé and P M Harari
Br J Cancer 92: 1819-1824; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602577
The use of radiofrequency in cancer FREE
A R Gillams
Br J Cancer 92: 1825-1829; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602582
Clinical Studies
Report of a Joint Cancer Research UK/Medical Research Council workshop on cancer cachexia research at the Royal College of Physicians, Tuesday, 2 December 2003 FREE
T E Steer
Br J Cancer 92: 1830-1833; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602565
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer FREE
L M Forrest, D C McMillan, C S McArdle, W J Angerson, K Dagg and H R Scott
Br J Cancer 92: 1834-1836; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602591
Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studies FREE
D R Camidge, K R Randall, J R Foster, C J Sadler, J A Wright, A R Soames, P J Laud, P D Smith and A M Hughes
Br J Cancer 92: 1837-1841; advance online publication, May 10, 2005; doi:10.1038/sj.bjc.6602558
Social and geographic disparities in access to reference care site for patients with colorectal cancer in France FREE
O Dejardin, A-M Bouvier, C Herbert, M Velten, A Buemi, P Delafosse, N Maarouf, S Boutreux and G Launoy
Br J Cancer 92: 1842-1845; advance online publication, May 10, 2005; doi:10.1038/sj.bjc.6602571
A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer FREE
M L Veronese, W Sun, B Giantonio, J Berlin, J Shults, L Davis, D G Haller and P J O'Dwyer
Br J Cancer 92: 1846-1849; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602569
Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer FREE
S T Kim, W K Kang, J H Kang, K W Park, J Lee, S-H Lee, J O Park, K Kim, W S Kim, C W Jung, Y S Park, Y-H Im and K Park
Br J Cancer 92: 1850-1854; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602575
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours FREE
A Awada, A Hendlisz, T Gil, S Bartholomeus, M Mano, D de Valeriola, D Strumberg, E Brendel, C G Haase, B Schwartz and M Piccart
Br J Cancer 92: 1855-1861; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602584
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients FREE
T F Greten, F Papendorf, J S Bleck, T Kirchhoff, T Wohlberedt, S Kubicka, J Klempnauer, M Galanski and M P Manns
Br J Cancer 92: 1862-1868; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602590
Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration FREE
A Wardley, N Davidson, P Barrett-Lee, A Hong, J Mansi, D Dodwell, R Murphy, T Mason and D Cameron
Br J Cancer 92: 1869-1876; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602551
Translational Therapeutics
Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients FREE
M Nishio, F Ohyanagi, A Horiike, Y Ishikawa, Y Satoh, S Okumura, K Nakagawa, K Nishio and T Horai
Br J Cancer 92: 1877-1880; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602585
Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines FREE
O Uziel, E Fenig, J Nordenberg, E Beery, H Reshef, J Sandbank, M Birenbaum, M Bakhanashvili, R Yerushalmi, D Luria and M Lahav
Br J Cancer 92: 1881-1891; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602592
Molecular Diagnostics
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid FREE
V Máximo, T Botelho, J Capela, P Soares, J Lima, A Taveira, T Amaro, A P Barbosa, A Preto, H R Harach, D Williams and M Sobrinho-Simões
Br J Cancer 92: 1892-1898; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602547
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells FREE
M Mandal, S Kim, M N Younes, S A Jasser, A K El-Naggar, G B Mills and J N Myers
Br J Cancer 92: 1899-1905; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602595
Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder FREE
H-L Cheng, H-S Liu, Y-J Lin, H H-W Chen, P-Y Hsu, T-Y Chang, C-L Ho, T-S Tzai and N-H Chow
Br J Cancer 92: 1906-1914; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602593
Aberrant expression of RAB1A in human tongue cancer FREE
K Shimada, K Uzawa, M Kato, Y Endo, M Shiiba, H Bukawa, H Yokoe, N Seki and H Tanzawa
Br J Cancer 92: 1915-1921; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602594
Genetics and Genomics
Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors FREE
F Weber, K Fukino, T Sawada, N Williams, K Sweet, R M Brena, C Plass, T Caldes, G L Mutter, M A Villalona-Calero and C Eng
Br J Cancer 92: 1922-1926; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602557
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas FREE
O Gubbay, W Guo, M T Rae, D Niven, S P Langdon and S G Hillier
Br J Cancer 92: 1927-1933; advance online publication, May 3, 2005; doi:10.1038/sj.bjc.6602568
Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours FREE
K Almstrup, C E Hoei-Hansen, J E Nielsen, U Wirkner, W Ansorge, N E Skakkebæk, E Rajpert-De Meyts and H Leffers
Br J Cancer 92: 1934-1941; advance online publication, April 26, 2005; doi:10.1038/sj.bjc.6602560
Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells FREE
J H Ohyashiki, H Hisatomi, K Nagao, S Honda, T Takaku, Y Zhang, G Sashida and K Ohyashiki
Br J Cancer 92: 1942-1947; advance online publication, April 12, 2005; doi:10.1038/sj.bjc.6602546
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer FREE
A Ballestrero, A Garuti, M Bertolotto, I Rocco, D Boy, A Nencioni, L Ottonello and F Patrone
Br J Cancer 92: 1948-1952; advance online publication, April 19, 2005; doi:10.1038/sj.bjc.6602563
Book Review
Cancer of the Skin FREE
I M Leigh
Br J Cancer 92: 1953-1954; doi:10.1038/sj.bjc.6602578
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
